NASDAQ:DXCM - Dexcom Stock Price, Price Target & More

$73.98 -0.45 (-0.60 %)
(As of 04/25/2018 02:30 PM ET)
Previous Close$74.43
Today's Range$73.04 - $74.33
52-Week Range$42.62 - $81.91
Volume397,683 shs
Average Volume1.23 million shs
Market Capitalization$6.46 billion
P/E Ratio-127.09
Dividend YieldN/A
Beta-0.01

About Dexcom (NASDAQ:DXCM)

Dexcom logoDexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers. Its products include DexCom G5 mobile continuous glucose monitoring system to communicate directly to patient's mobile device; DexCom G4 PLATINUM system for continuous use by adults with diabetes; and DexCom Share, a remote monitoring system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC to develop a series of next-generation CGM products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.

Receive DXCM News and Ratings via Email

Sign-up to receive the latest news and ratings for DXCM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNASDAQ:DXCM
CUSIP25213110
Phone858-200-0200

Debt

Debt-to-Equity Ratio0.78%
Current Ratio5.36%
Quick Ratio5.04%

Price-To-Earnings

Trailing P/E Ratio-127.09
Forward P/E Ratio-137.00
P/E GrowthN/A

Sales & Book Value

Annual Sales$718.50 million
Price / Sales9.07
Cash FlowN/A
Price / CashN/A
Book Value$4.83 per share
Price / Book15.32

Profitability

EPS (Most Recent Fiscal Year)($0.58)
Net Income$-50,200,000.00
Net Margins-6.99%
Return on Equity-13.99%
Return on Assets-6.67%

Miscellaneous

Employees2,990
Outstanding Shares88,070,000

How to Become a New Pot Stock Millionaire

Dexcom (NASDAQ:DXCM) Frequently Asked Questions

What is Dexcom's stock symbol?

Dexcom trades on the NASDAQ under the ticker symbol "DXCM."

How were Dexcom's earnings last quarter?

Dexcom (NASDAQ:DXCM) released its earnings results on Tuesday, February, 27th. The medical device company reported $0.10 EPS for the quarter, topping analysts' consensus estimates of $0.03 by $0.07. The medical device company had revenue of $221 million for the quarter, compared to the consensus estimate of $217.82 million. Dexcom had a negative net margin of 6.99% and a negative return on equity of 13.99%. View Dexcom's Earnings History.

When is Dexcom's next earnings date?

Dexcom is scheduled to release their next quarterly earnings announcement on Wednesday, May, 2nd 2018. View Earnings Estimates for Dexcom.

What price target have analysts set for DXCM?

21 equities research analysts have issued 1-year price targets for Dexcom's shares. Their forecasts range from $40.00 to $95.00. On average, they anticipate Dexcom's stock price to reach $67.3824 in the next year. View Analyst Ratings for Dexcom.

Are investors shorting Dexcom?

Dexcom saw a drop in short interest in April. As of April 13th, there was short interest totalling 12,600,819 shares, a drop of 10.9% from the March 30th total of 14,147,733 shares. Based on an average trading volume of 1,326,047 shares, the short-interest ratio is presently 9.5 days. Currently, 14.9% of the company's stock are sold short.

Who are some of Dexcom's key competitors?

Who are Dexcom's key executives?

Dexcom's management team includes the folowing people:
  • Mr. Kevin R. Sayer, Chief Exec. Officer, Pres and Director (Age 60)
  • Mr. Donald M. Abbey, Exec. VP of Quality & Information Technology (Age 51)
  • Mr. Steven R. Pacelli, Exec. VP of Strategy & Corp. Devel. (Age 46)
  • Mr. Richard B. Doubleday, Chief Commercial Officer and Exec. VP (Age 55)
  • Mr. Terrance H. Gregg, Exec. Chairman (Age 69)

Has Dexcom been receiving favorable news coverage?

News headlines about DXCM stock have been trending positive recently, Accern Sentiment reports. The research group identifies positive and negative news coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Dexcom earned a media sentiment score of 0.44 on Accern's scale. They also assigned media coverage about the medical device company an impact score of 47.82 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the near future.

Who are Dexcom's major shareholders?

Dexcom's stock is owned by a variety of of institutional and retail investors. Top institutional investors include ARTISAN PARTNERS LIMITED PARTNERSHIP (2.30%). Company insiders that own Dexcom stock include Andrew K Balo, Barbara Kahn, Jacob Steven Leach, Jay S Skyler, Jeffrey Moy, Jess Roper, John Lister, Jonathan T Md Lord, Jorge A Valdes, Kevin R Sayer, Mark G Foletta, Richard Doubleday, Steven R Altman, Steven Robert Pacelli and Terrance H Gregg. View Institutional Ownership Trends for Dexcom.

How do I buy shares of Dexcom?

Shares of DXCM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Dexcom's stock price today?

One share of DXCM stock can currently be purchased for approximately $73.98.

How big of a company is Dexcom?

Dexcom has a market capitalization of $6.46 billion and generates $718.50 million in revenue each year. The medical device company earns $-50,200,000.00 in net income (profit) each year or ($0.58) on an earnings per share basis. Dexcom employs 2,990 workers across the globe.

How can I contact Dexcom?

Dexcom's mailing address is 6340 SEQUENCE DRIVE, SAN DIEGO CA, 92121. The medical device company can be reached via phone at 858-200-0200 or via email at [email protected]


MarketBeat Community Rating for Dexcom (DXCM)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  579 (Vote Outperform)
Underperform Votes:  297 (Vote Underperform)
Total Votes:  876
MarketBeat's community ratings are surveys of what our community members think about Dexcom and other stocks. Vote "Outperform" if you believe DXCM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DXCM will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Dexcom (NASDAQ:DXCM) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
22 Wall Street analysts have issued ratings and price targets for Dexcom in the last 12 months. Their average twelve-month price target is $67.3824, suggesting that the stock has a possible downside of 8.92%. The high price target for DXCM is $95.00 and the low price target for DXCM is $40.00. There are currently 2 sell ratings, 7 hold ratings and 13 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.502.622.572.64
Ratings Breakdown: 2 Sell Rating(s)
7 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
6 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
7 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
8 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $67.3824$67.0294$68.50$72.1944
Price Target Upside: 8.92% downside0.43% upside20.70% upside53.02% upside

Dexcom (NASDAQ:DXCM) Consensus Price Target History

Price Target History for Dexcom (NASDAQ:DXCM)

Dexcom (NASDAQ:DXCM) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/9/2018StephensReiterated RatingBuy$78.00MediumView Rating Details
4/4/2018Goldman SachsInitiated CoverageSell -> Sell$74.69 -> $57.00HighView Rating Details
4/3/2018GuggenheimInitiated CoverageNeutral -> NeutralHighView Rating Details
3/29/2018Canaccord GenuityBoost Price TargetBuy -> Positive$71.00 -> $80.00MediumView Rating Details
3/29/2018BMO Capital MarketsUpgradeOutperform$78.00MediumView Rating Details
3/29/2018OppenheimerSet Price TargetBuy$67.00 -> $80.00MediumView Rating Details
3/29/2018Piper JaffraySet Price TargetBuy$80.00MediumView Rating Details
3/23/2018Robert W. BairdUpgradeNeutral -> Outperform$58.00HighView Rating Details
3/4/2018Northcoast ResearchReiterated RatingBuyHighView Rating Details
1/16/2018Northland SecuritiesReiterated RatingSell$40.00LowView Rating Details
1/8/2018BarclaysReiterated RatingHold$60.00HighView Rating Details
12/22/2017Jefferies GroupBoost Price TargetTop Pick -> Buy$58.00 -> $70.00LowView Rating Details
11/3/2017Morgan StanleyLower Price TargetNeutral$72.00 -> $52.00N/AView Rating Details
10/4/2017WedbushReiterated RatingBuy$76.00LowView Rating Details
9/29/2017Leerink SwannReiterated RatingBuy$85.00 -> $57.00HighView Rating Details
9/29/2017Raymond JamesDowngradeOutperform -> Mkt PerformHighView Rating Details
9/28/2017CowenLower Price TargetOutperform$90.00 -> $64.00HighView Rating Details
9/28/2017CitigroupDowngradeOutperform -> Market PerformHighView Rating Details
9/28/2017JPMorgan ChaseDowngradeOverweight -> Neutral$93.00 -> $71.00HighView Rating Details
5/7/2017B. RileyReiterated RatingBuy$95.00HighView Rating Details
5/3/2017BTIG ResearchDowngradeBuy -> NeutralHighView Rating Details
4/27/2017William BlairReiterated RatingOutperformLowView Rating Details
4/4/2017Royal Bank of CanadaReiterated RatingOutperform$87.00MediumView Rating Details
12/19/2016UBSUpgradeMarket Perform -> OutperformN/AView Rating Details
9/16/2016DesjardinsUpgradeHold -> BuyN/AView Rating Details
8/3/2016BenchmarkLower Price TargetBuy$106.00 -> $86.00N/AView Rating Details
7/15/2016Deutsche BankBoost Price TargetBuy$90.00 -> $98.00N/AView Rating Details
(Data available from 4/25/2016 forward)

Earnings

Dexcom (NASDAQ:DXCM) Earnings History and Estimates Chart

Earnings by Quarter for Dexcom (NASDAQ:DXCM)

Dexcom (NASDAQ:DXCM) Earnings Estimates

2018 EPS Consensus Estimate: ($0.41)
2019 EPS Consensus Estimate: ($0.28)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20186($0.43)($0.13)($0.30)
Q2 20186($0.26)$0.05($0.14)
Q3 20186($0.16)$0.15($0.04)
Q4 20186($0.04)$0.28$0.06
Q1 20192($0.38)($0.03)($0.21)
Q2 20192($0.13)($0.02)($0.08)
Q3 20192($0.05)($0.01)($0.03)
Q4 20192$0.01$0.05$0.03

Dexcom (NASDAQ DXCM) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/30/2018($0.28)N/AView Earnings Details
2/27/2018Q4 2017$0.03$0.10$217.82 million$221.00 millionViewListenView Earnings Details
11/1/2017Q3 2017($0.15)($0.04)$183.42 million$184.60 millionViewN/AView Earnings Details
8/1/2017Q2 2017($0.23)($0.16)$166.54 million$170.60 millionViewListenView Earnings Details
5/2/2017Q1 2017($0.55)($0.49)$143.94 million$142.30 millionViewListenView Earnings Details
2/28/2017Q416($0.10)($0.09)$167.51 million$171.20 millionViewListenView Earnings Details
11/1/2016Q316($0.14)($0.22)$146.09 million$148.60 millionViewN/AView Earnings Details
8/2/2016Q216($0.12)($0.24)$132.48 million$137.30 millionViewN/AView Earnings Details
4/27/2016Q116($0.20)($0.23)$110.37 million$116.20 millionViewListenView Earnings Details
2/23/2016Q415$0.01$0.02$122.93 million$130.80 millionViewListenView Earnings Details
11/4/2015Q315($0.01)($0.07)$97.47 million$105.20 millionViewN/AView Earnings Details
8/5/2015Q215($0.03)($0.05)$84.74 million$93.20 millionViewN/AView Earnings Details
4/29/2015Q115($0.11)($0.17)$71.32 million$72.80 millionViewN/AView Earnings Details
2/25/2015Q414($0.03)$0.02$79.65 million$84.30 millionViewN/AView Earnings Details
11/6/2014Q314($0.05)($0.08)$60.20 million$67.90 millionViewN/AView Earnings Details
8/6/2014Q214($0.10)($0.10)$52.45 million$58.80 millionViewListenView Earnings Details
5/1/2014Q114($0.08)($0.17)$44.15 million$47.10 millionViewListenView Earnings Details
2/20/2014Q413($0.07)($0.04)$48.53 million$51.30 millionViewListenView Earnings Details
11/6/2013Q313($0.13)($0.09)$35.90 million$42.90 millionViewN/AView Earnings Details
8/7/2013Q2 2013($0.16)($0.14)$31.14 million$35.80 millionViewN/AView Earnings Details
5/1/2013Q1 2013($0.17)($0.16)$28.26 million$29.60 millionViewN/AView Earnings Details
2/21/2013Q4 2012($0.15)($0.12)$31.09 million$33.30 millionViewN/AView Earnings Details
11/1/2012Q312($0.22)($0.25)$23.14 million$23.10 millionViewN/AView Earnings Details
8/6/2012($0.20)($0.21)ViewN/AView Earnings Details
5/2/2012($0.19)($0.21)ViewN/AView Earnings Details
2/23/2012($0.17)($0.18)ViewN/AView Earnings Details
11/2/2011($0.15)($0.20)ViewN/AView Earnings Details
8/3/2011($0.11)($0.11)ViewN/AView Earnings Details
5/3/2011($0.19)($0.19)ViewN/AView Earnings Details
3/3/2011($0.19)($0.16)ViewN/AView Earnings Details
11/4/2010Q3 2010($0.17)($0.23)ViewN/AView Earnings Details
8/3/2010Q2 2010($0.20)($0.20)ViewN/AView Earnings Details
5/5/2010Q1 2010($0.24)($0.27)ViewN/AView Earnings Details
3/9/2010Q4 2009($0.27)($0.25)ViewN/AView Earnings Details
11/4/2009Q3 2009($0.32)($0.29)ViewN/AView Earnings Details
8/3/2009Q2 2009($0.29)($0.33)ViewN/AView Earnings Details
5/6/2009Q1 2009($0.32)($0.30)ViewN/AView Earnings Details
3/5/2009Q4 2008($0.44)($0.45)ViewN/AView Earnings Details
11/10/2008Q3 2008($0.46)($0.50)ViewN/AView Earnings Details
8/5/2008Q2 2008($0.46)($0.48)ViewN/AView Earnings Details
5/8/2008Q1 2008($0.39)($0.44)ViewN/AView Earnings Details
3/11/2008Q4 2007($0.41)($0.43)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Dexcom (NASDAQ:DXCM) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Dexcom (NASDAQ DXCM) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.70%
Insider Trading History for Dexcom (NASDAQ:DXCM)
Institutional Ownership by Quarter for Dexcom (NASDAQ:DXCM)

Dexcom (NASDAQ DXCM) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/16/2018Terrance H GreggInsiderSell10,000$73.04$730,400.00521,674View SEC Filing  
3/23/2018Richard DoubledayEVPSell2,581$68.44$176,643.6494,429View SEC Filing  
3/15/2018Terrance H GreggInsiderSell10,000$65.51$655,100.00521,674View SEC Filing  
2/23/2018Richard DoubledayEVPSell1,638$56.32$92,252.1665,049View SEC Filing  
2/15/2018Terrance H GreggChairmanSell10,000$55.91$559,100.00484,559View SEC Filing  
1/23/2018Richard DoubledayEVPSell1,635$54.67$89,385.4565,049View SEC Filing  
1/16/2018Terrance H GreggInsiderSell10,000$56.86$568,600.00484,559View SEC Filing  
12/26/2017Richard DoubledayEVPSell1,635$56.39$92,197.6565,049View SEC Filing  
12/12/2017Kevin R. SayerCEOSell6,000$58.85$353,100.00View SEC Filing  
12/11/2017Andrew K. BaloEVPSell3,245$61.23$198,691.35View SEC Filing  
11/29/2017Andrew K. BaloEVPSell6,490$60.00$389,400.00View SEC Filing  
11/27/2017Mark G FolettaDirectorSell2,500$54.95$137,375.004,952View SEC Filing  
11/24/2017Richard DoubledayEVPSell1,635$55.53$90,791.5565,049View SEC Filing  
11/20/2017Barbara KahnDirectorSell3,000$54.58$163,740.004,353View SEC Filing  
11/20/2017Kevin R. SayerCEOSell12,000$55.00$660,000.00View SEC Filing  
11/6/2017Steven R AltmanDirectorBuy10,000$49.61$496,100.004,353View SEC Filing  
10/23/2017Richard DoubledayEVPSell1,635$44.82$73,280.7065,049View SEC Filing  
9/25/2017Steven Robert PacelliEVPSell1,450$69.81$101,224.50View SEC Filing  
9/20/2017Kevin R. SayerCEOSell6,000$69.34$416,040.00View SEC Filing  
9/11/2017Andrew K. BaloEVPSell3,244$72.27$234,443.88View SEC Filing  
8/23/2017Richard DoubledayEVPSell1,635$75.26$123,050.1072,395View SEC Filing  
8/11/2017Kevin R. SayerCEOSell6,000$69.77$418,620.00View SEC Filing  
8/10/2017Andrew K. BaloEVPSell3,244$71.18$230,907.92View SEC Filing  
7/24/2017Steven Robert PacelliEVPSell1,450$69.47$100,731.50View SEC Filing  
7/12/2017Kevin R. SayerCEOSell6,000$71.86$431,160.00View SEC Filing  
7/10/2017Andrew K. BaloEVPSell3,200$71.55$228,960.00View SEC Filing  
6/23/2017Steven Robert PacelliEVPSell1,450$78.19$113,375.50View SEC Filing  
6/12/2017Andrew K. BaloEVPSell3,200$69.06$220,992.00View SEC Filing  
6/12/2017Kevin R. SayerCEOSell6,000$69.07$414,420.00View SEC Filing  
5/23/2017Richard DoubledayEVPSell3,182$68.29$217,298.7872,395View SEC Filing  
5/17/2017Kevin R SayerCEOSell8,649$68.39$591,505.11347,329View SEC Filing  
5/10/2017Andrew K. BaloEVPSell3,200$71.93$230,176.00View SEC Filing  
4/24/2017Richard DoubledayEVPSell3,182$75.78$241,131.9697,815View SEC Filing  
4/20/2017Terrance H GreggInsiderSell15,000$74.10$1,111,500.00454,559View SEC Filing  
4/17/2017Kevin R SayerCEOSell10,000$75.63$756,300.00353,680View SEC Filing  
4/10/2017Andrew K. BaloEVPSell3,200$78.19$250,208.00View SEC Filing  
3/23/2017Richard DoubledayEVPSell3,182$76.38$243,041.1697,815View SEC Filing  
3/22/2017Jess RoperCFOSell2,000$75.97$151,940.0046,497View SEC Filing  
3/17/2017Kevin R SayerCEOSell10,000$77.82$778,200.00353,680View SEC Filing  
3/14/2017Jacob Steven LeachSVPSell21,317$77.63$1,654,838.71View SEC Filing  
3/13/2017Jorge A. ValdesInsiderSell14,400$77.74$1,119,456.00View SEC Filing  
3/9/2017John ListerInsiderSell3,000$77.67$233,010.00View SEC Filing  
3/6/2017Jay S SkylerDirectorSell31,890$78.13$2,491,565.705,011View SEC Filing  
2/23/2017Richard DoubledayEVPSell3,182$78.42$249,532.4483,582View SEC Filing  
1/23/2017Richard DoubledayEVPSell3,182$79.50$252,969.0083,582View SEC Filing  
1/18/2017Jess RoperCFOSell3,012$85.01$256,050.1255,976View SEC Filing  
1/17/2017Kevin R SayerCEOSell10,000$85.94$859,400.00309,391View SEC Filing  
1/13/2017John ListerInsiderSell15,000$79.36$1,190,400.0085,598View SEC Filing  
1/10/2017Andrew K BaloEVPSell3,200$62.86$201,152.00109,545View SEC Filing  
1/9/2017Jorge A ValdesInsiderSell10,900$63.02$686,918.0079,334View SEC Filing  
12/23/2016Richard DoubledayEVPSell3,182$62.17$197,824.9483,582View SEC Filing  
12/9/2016Jorge A ValdesInsiderSell10,000$64.81$648,100.0074,971View SEC Filing  
10/24/2016Jess RoperCFOSell2,471$80.75$199,533.25View SEC Filing  
10/24/2016Steven Robert PacelliEVPSell10,300$81.95$844,085.00View SEC Filing  
10/19/2016Andrew K. BaloEVPSell4,997$82.31$411,303.07View SEC Filing  
10/14/2016Kevin R. SayerCEOSell7,000$81.87$573,090.00View SEC Filing  
10/10/2016John ListerInsiderSell3,560$84.41$300,499.60View SEC Filing  
10/5/2016Andrew K. BaloEVPSell5,000$82.55$412,750.00View SEC Filing  
9/23/2016Richard DoubledayEVPSell3,182$93.97$299,012.5483,582View SEC Filing  
9/22/2016Jess RoperCFOSell2,470$93.99$232,155.30View SEC Filing  
9/21/2016Andrew K. BaloEVPSell5,000$92.87$464,350.00View SEC Filing  
9/14/2016Kevin R. SayerCEOSell7,000$91.79$642,530.00View SEC Filing  
9/12/2016Jay S SkylerDirectorSell10,000$93.00$930,000.005,011View SEC Filing  
9/12/2016Jorge A ValdesInsiderSell19,071$93.07$1,774,937.97103,667View SEC Filing  
9/9/2016Jay S SkylerDirectorSell25,000$94.07$2,351,750.005,011View SEC Filing  
9/9/2016John ListerInsiderSell3,560$93.65$333,394.00View SEC Filing  
9/8/2016Terrance H GreggInsiderSell10,740$95.29$1,023,414.60451,486View SEC Filing  
9/7/2016Andrew K BaloEVPSell4,999$94.45$472,155.55135,009View SEC Filing  
9/7/2016Mark G. FolettaDirectorSell1,800$94.63$170,334.00View SEC Filing  
9/1/2016Jonathan T. Md LordDirectorSell10,000$91.50$915,000.00View SEC Filing  
8/30/2016Terrance H GreggInsiderSell10,000$92.14$921,400.00451,486View SEC Filing  
8/24/2016Andrew K BaloEVPSell5,000$91.72$458,600.00134,979View SEC Filing  
8/24/2016Terrance H GreggInsiderSell10,000$92.72$927,200.00451,486View SEC Filing  
8/23/2016Steven Robert PacelliEVPSell10,300$90.74$934,622.00View SEC Filing  
8/23/2016Terrance H GreggChairmanSell10,000$91.11$911,100.00451,486View SEC Filing  
8/22/2016Terrance H GreggChairmanSell10,000$90.51$905,100.00451,486View SEC Filing  
8/19/2016Jay S SkylerDirectorSell25,000$90.77$2,269,250.005,011View SEC Filing  
8/19/2016Terrance H GreggInsiderSell40,000$90.70$3,628,000.00451,486View SEC Filing  
8/15/2016Kevin R. SayerCEOSell7,000$90.78$635,460.00View SEC Filing  
8/15/2016Terrance H GreggChairmanSell14,942$91.01$1,359,871.42451,486View SEC Filing  
8/12/2016Jonathan T. Md LordDirectorSell10,000$90.64$906,400.00View SEC Filing  
8/11/2016Terrance H GreggInsiderSell10,900$91.03$992,227.00451,486View SEC Filing  
8/10/2016Andrew K BaloEVPSell5,000$90.26$451,300.00134,979View SEC Filing  
8/9/2016Jorge A ValdesInsiderSell32,000$91.06$2,913,920.00123,667View SEC Filing  
8/9/2016Kevin R SayerCEOSell20,000$90.98$1,819,600.00362,227View SEC Filing  
8/8/2016Barbara KahnDirectorSell6,000$90.52$543,120.0012,291View SEC Filing  
8/5/2016Terrance H. GreggInsiderSell35,000$79.81$2,793,350.00View SEC Filing  
8/1/2016Jeffrey MoySVPSell15,000$92.33$1,384,950.00107,582View SEC Filing  
7/27/2016Andrew K BaloEVPSell5,000$88.14$440,700.00134,979View SEC Filing  
7/25/2016Richard DoubledayEVPSell3,182$87.31$277,820.4292,250View SEC Filing  
7/22/2016Jeffrey MoySVPSell10,000$88.48$884,800.0076,333View SEC Filing  
7/19/2016Jeffrey MoySVPSell12,843$83.78$1,075,986.54View SEC Filing  
7/13/2016Andrew K BaloEVPSell5,000$80.12$400,600.00134,979View SEC Filing  
7/13/2016Kevin R. SayerCEOSell7,000$79.92$559,440.00View SEC Filing  
7/11/2016Jorge A ValdesInsiderSell32,000$79.36$2,539,520.00123,667View SEC Filing  
6/29/2016Andrew K BaloEVPSell5,000$78.10$390,500.00134,979View SEC Filing  
6/29/2016Jeffrey MoySVPSell4,557$80.00$364,560.0076,333View SEC Filing  
6/23/2016Steven Robert PacelliEVPSell10,300$77.40$797,220.00View SEC Filing  
6/20/2016Andrew K BaloEVPSell55,000$75.00$4,125,000.00184,979View SEC Filing  
6/20/2016Jeffrey MoySVPSell7,209$77.00$555,093.0076,333View SEC Filing  
6/20/2016Kevin R. SayerCEOSell35,000$75.00$2,625,000.00View SEC Filing  
6/9/2016Jeffrey MoySVPSell6,910$74.00$511,340.0076,333View SEC Filing  
6/9/2016John ListerInsiderSell3,560$73.27$260,841.2065,894View SEC Filing  
6/8/2016Jeffrey MoySVPSell6,866$71.00$487,486.0076,333View SEC Filing  
6/8/2016Jorge A ValdesInsiderSell18,038$72.06$1,299,818.28101,667View SEC Filing  
6/8/2016Steven Robert PacelliEVPSell18,239$70.88$1,292,780.32182,518View SEC Filing  
6/7/2016Jess RoperCFOSell3,471$69.00$239,499.0085,248View SEC Filing  
5/23/2016Richard DoubledayEVPSell1,674$63.59$106,449.6694,900View SEC Filing  
5/18/2016Jorge A ValdesInsiderSell20,000$61.75$1,235,000.00111,667View SEC Filing  
5/16/2016Terrance H GreggChairmanSell20,000$62.72$1,254,400.00472,991View SEC Filing  
5/12/2016Barbara KahnDirectorSell3,000$60.72$182,160.0042,804View SEC Filing  
5/11/2016Terrance H GreggChairmanSell8,600$64.32$553,152.00472,991View SEC Filing  
5/9/2016John ListerInsiderSell3,560$62.50$222,500.0069,454View SEC Filing  
5/9/2016Terrance H GreggChairmanSell12,168$62.42$759,526.56472,991View SEC Filing  
4/27/2016Jorge A ValdesInsiderSell10,000$70.00$700,000.0091,667View SEC Filing  
4/27/2016Steven Robert PacelliEVPSell2,361$70.39$166,190.79201,757View SEC Filing  
4/25/2016Jess RoperCFOSell3,471$69.00$239,499.0088,719View SEC Filing  
4/25/2016Richard DoubledayEVPSell1,666$69.15$115,203.9094,900View SEC Filing  
4/12/2016John ListerInsiderSell3,704$65.78$243,649.1273,014View SEC Filing  
4/11/2016Terrance H GreggChairmanSell2,169$68.00$147,492.00475,159View SEC Filing  
4/4/2016Jorge A ValdesInsiderSell20,000$70.08$1,401,600.00111,667View SEC Filing  
4/4/2016Steven Robert PacelliEVPSell20,600$70.62$1,454,772.00204,118View SEC Filing  
3/31/2016Jess RoperCFOSell3,470$69.00$239,430.0092,190View SEC Filing  
3/23/2016Richard DoubledayEVPSell1,666$61.76$102,892.16123,022View SEC Filing  
3/22/2016Terrance H GreggChairmanSell25,000$59.51$1,487,750.00477,328View SEC Filing  
3/14/2016John ListerInsiderSell3,560$63.75$226,950.0080,278View SEC Filing  
3/7/2016Barbara KahnDirectorSell5,000$67.04$335,200.0045,804View SEC Filing  
2/23/2016Richard DoubledayEVPSell1,666$64.36$107,223.76100,483View SEC Filing  
2/18/2016John ListerVPSell3,560$62.50$222,500.00View SEC Filing  
1/25/2016Steven Robert PacelliEVPSell10,300$73.24$754,372.00205,914View SEC Filing  
1/22/2016Jess RoperCFOSell3,518$72.97$256,708.4675,989View SEC Filing  
1/20/2016Kevin R SayerCEOSell7,000$75.00$525,000.00336,402View SEC Filing  
1/12/2016Jorge A ValdesInsiderSell5,610$80.16$449,697.6092,437View SEC Filing  
1/11/2016Jorge A ValdesInsiderSell1,641$78.43$128,703.6392,437View SEC Filing  
1/8/2016John ListerVPSell3,560$82.57$293,949.2097,710View SEC Filing  
12/23/2015Richard DoubledayEVPSell1,666$82.22$136,978.52100,483View SEC Filing  
12/22/2015Jess RoperCFOSell3,417$81.19$277,426.2379,507View SEC Filing  
12/17/2015Andrew K. BaloEVPSell7,500$82.52$618,900.00107,680View SEC Filing  
12/14/2015John ListerVPSell3,560$82.50$293,700.00101,270View SEC Filing  
12/9/2015Jorge A. ValdesinsiderSell10,000$85.74$857,400.0092,437View SEC Filing  
12/8/2015John ListerVPSell2,476$87.16$215,808.16104,830View SEC Filing  
12/4/2015Terrance H. GreggChairmanSell10,000$86.79$867,900.00459,018View SEC Filing  
12/3/2015Andrew K. BaloEVPSell7,500$86.37$647,775.00107,680View SEC Filing  
12/2/2015Terrance H. GreggChairmanSell10,000$87.05$870,500.00459,018View SEC Filing  
11/30/2015Terrance H. GreggChairmanSell5,000$86.50$432,500.00459,018View SEC Filing  
11/25/2015Andrew K. BaloEVPSell7,500$87.49$656,175.00107,680View SEC Filing  
11/25/2015Terrance H. GreggChairmanSell15,000$87.53$1,312,950.00459,018View SEC Filing  
11/24/2015Andrew K. BaloEVPSell10,000$86.43$864,300.00107,680View SEC Filing  
11/24/2015Terrance H. GreggChairmanSell15,497$86.54$1,341,110.38459,018View SEC Filing  
11/23/2015Richard DoubledayEVPSell1,666$85.85$143,026.10100,483View SEC Filing  
11/20/2015Terrance H. GreggChairmanSell22,003$86.48$1,902,819.44459,018View SEC Filing  
11/18/2015Jess RoperCFOSell7,000$84.15$589,050.0082,924View SEC Filing  
11/16/2015Terrance H. GreggChairmanSell20,000$83.89$1,677,800.00459,018View SEC Filing  
11/12/2015Jess RoperCFOSell20,000$84.07$1,681,400.0083,924View SEC Filing  
11/11/2015Andrew K. BaloEVPSell7,500$84.50$633,750.00113,157View SEC Filing  
10/23/2015Richard DoubledayEVPSell1,666$79.27$132,063.82100,483View SEC Filing  
10/20/2015Andrew K BaloEVPSell4,538$81.46$369,665.48113,157View SEC Filing  
10/19/2015Jess RoperCFOSell7,000$83.37$583,590.0098,424View SEC Filing  
10/15/2015Terrance H GreggChairmanSell15,000$77.92$1,168,800.00459,018View SEC Filing  
10/6/2015Andrew K BaloEVPSell8,216$82.29$676,094.64117,695View SEC Filing  
9/23/2015Steven Robert PacelliEVPSell14,000$98.08$1,373,120.00216,214View SEC Filing  
9/21/2015Andrew K BaloEVPSell7,859$100.72$791,558.48125,911View SEC Filing  
9/18/2015Jess RoperCFOSell7,000$101.22$708,540.0099,424View SEC Filing  
9/15/2015Terrance H. GreggChairmanSell29,999$96.22$2,886,503.78459,018View SEC Filing  
9/11/2015Terrance H. GreggChairmanSell47,500$96.50$4,583,750.00459,018View SEC Filing  
9/10/2015Terrance H. GreggChairmanSell62,501$95.91$5,994,470.91459,018View SEC Filing  
9/9/2015Jonathan T Md LordDirectorSell10,000$90.96$909,600.00131,582View SEC Filing  
9/8/2015Andrew K BaloEVPSell7,500$89.53$671,475.00142,590View SEC Filing  
9/8/2015John ListerVPSell2,642$89.36$236,089.12121,347View SEC Filing  
9/8/2015Terrance H. GreggChairmanSell25,000$90.85$2,271,250.00459,018View SEC Filing  
9/1/2015Jeffrey MoySVPSell8,881$90.61$804,707.4190,000View SEC Filing  
9/1/2015Jorge A. ValdesinsiderSell20,000$91.22$1,824,400.00116,207View SEC Filing  
8/28/2015Steven Robert PacelliEVPSell19,854$94.67$1,879,578.18228,792View SEC Filing  
8/24/2015Steven Robert PacelliEVPSell14,000$84.18$1,178,520.00248,646View SEC Filing  
8/20/2015Andrew K BaloEVPSell7,500$92.47$693,525.00150,090View SEC Filing  
8/18/2015Steven R AltmanDirectorSell5,000$96.69$483,450.00View SEC Filing  
8/17/2015Jay S SkylerDirectorSell20,000$96.65$1,933,000.00View SEC Filing  
8/17/2015Terrance H GreggChairmanSell15,000$96.71$1,450,650.00View SEC Filing  
8/14/2015Kevin R SayerCEOSell35,000$97.41$3,409,350.00View SEC Filing  
7/23/2015Richard DoubledayEVPSell9,641$85.37$823,052.17View SEC Filing  
7/22/2015Andrew K BaloEVPSell10,214$84.78$865,942.92View SEC Filing  
7/21/2015Jeffrey MoySVPSell3,786$83.48$316,055.28View SEC Filing  
7/20/2015Jess RoperCFOSell7,000$83.74$586,180.00View SEC Filing  
7/17/2015Terrance H GreggChairmanSell50,750$83.07$4,215,802.50View SEC Filing  
7/15/2015Jay S SkylerDirectorSell20,000$81.69$1,633,800.00View SEC Filing  
7/8/2015Andrew K BaloEVPSell4,494$80.22$360,508.68View SEC Filing  
7/8/2015John ListerVPSell1,776$79.94$141,973.44View SEC Filing  
7/8/2015Jorge A ValdesInsiderSell50,000$79.83$3,991,500.00View SEC Filing  
7/7/2015Jeffrey MoySVPSell5,000$79.32$396,600.00View SEC Filing  
6/23/2015Jeffrey MoySVPSell5,154$77.54$399,641.16View SEC Filing  
6/23/2015Steven Robert PacelliEVPSell14,000$77.53$1,085,420.00View SEC Filing  
6/18/2015Jess RoperCFOSell7,000$77.10$539,700.00View SEC Filing  
6/15/2015Jay S SkylerDirectorSell20,000$70.67$1,413,400.00View SEC Filing  
6/15/2015Terrance H GreggChairmanSell15,000$70.94$1,064,100.00View SEC Filing  
6/12/2015Terrance H. GreggChairmanSell25,000$72.30$1,807,500.00459,018View SEC Filing  
6/11/2015Jeffrey MoySVPSell9,869$73.00$720,437.00View SEC Filing  
6/9/2015Andrew K BaloEVPSell7,500$70.62$529,650.00View SEC Filing  
6/9/2015Jeffrey MoySVPSell5,000$70.63$353,150.00View SEC Filing  
6/9/2015Jorge A ValdesInsiderSell19,680$71.32$1,403,577.60View SEC Filing  
6/8/2015John ListerVPSell1,776$72.03$127,925.28View SEC Filing  
6/8/2015Jorge A ValdesInsiderSell8,243$72.07$594,073.01View SEC Filing  
6/3/2015Terrance H GreggChairmanSell40,000$72.77$2,910,800.00View SEC Filing  
6/2/2015Terrance H GreggChairmanSell5,000$73.12$365,600.00View SEC Filing  
6/1/2015Terrance H GreggChairmanSell10,000$72.75$727,500.00View SEC Filing  
5/27/2015Jeffrey MoySVPSell21,791$69.60$1,516,653.60View SEC Filing  
5/27/2015Richard DoubledayEVPSell3,258$70.73$230,438.34View SEC Filing  
5/18/2015Andrew K BaloEVPSell7,500$68.46$513,450.00View SEC Filing  
5/18/2015Jeffrey MoySVPSell15,586$69.20$1,078,551.20View SEC Filing  
5/18/2015Jess RoperCFOSell7,000$69.27$484,890.00View SEC Filing  
5/15/2015Terrance H GreggChairmanSell82,500$69.24$5,712,300.00View SEC Filing  
5/12/2015Jeffrey MoySVPSell20,303$67.84$1,377,355.52View SEC Filing  
5/12/2015Jorge A ValdesInsiderSell30,878$68.27$2,108,041.06View SEC Filing  
5/11/2015Jeffrey MoySVPSell15,303$68.25$1,044,429.75View SEC Filing  
5/11/2015Terrance H GreggChairmanSell3,517$68.65$241,442.05View SEC Filing  
5/8/2015Terrance H GreggChairmanSell91,483$67.85$6,207,121.55View SEC Filing  
5/4/2015Kevin R SayerCEOSell25,000$68.01$1,700,250.00View SEC Filing  
4/28/2015Jeffrey MoySVPSell10,000$68.41$684,100.00View SEC Filing  
4/27/2015Jeffrey MoySVPSell5,000$69.27$346,350.00View SEC Filing  
4/23/2015Steven Robert PacelliEVPSell39,709$69.63$2,764,937.67View SEC Filing  
4/20/2015Jess RoperCFOSell7,000$68.05$476,350.00View SEC Filing  
4/15/2015Terrance H GreggChairmanSell15,000$67.56$1,013,400.00View SEC Filing  
4/14/2015Jeffrey MoySVPSell20,766$66.63$1,383,638.58View SEC Filing  
4/9/2015Andrew K BaloEVPSell7,500$64.55$484,125.00View SEC Filing  
4/9/2015Jorge A ValdesInsiderSell19,684$64.38$1,267,255.92View SEC Filing  
4/8/2015John ListerVPSell5,039$63.84$321,689.76View SEC Filing  
3/25/2015Andrew K BaloEVPSell7,500$61.05$457,875.00View SEC Filing  
3/23/2015Steven Robert PacelliEVPSell14,000$61.33$858,620.00View SEC Filing  
3/18/2015Jess RoperCFOSell7,000$62.43$437,010.00View SEC Filing  
3/17/2015Terrance H GreggChairmanSell15,000$62.82$942,300.00View SEC Filing  
3/13/2015Jay S SkylerDirectorSell45,000$60.01$2,700,450.00View SEC Filing  
3/12/2015Jorge A ValdesInsiderSell11,138$59.78$665,829.64View SEC Filing  
3/12/2015Richard DoubledayEVPSell20,000$59.23$1,184,600.00View SEC Filing  
3/9/2015John ListerVPSell5,039$58.77$296,142.03View SEC Filing  
3/9/2015Jorge A ValdesInsiderSell8,244$58.77$484,499.88View SEC Filing  
2/23/2015Richard DoubledayEVPSell4,000$63.58$254,320.00View SEC Filing  
2/9/2015John ListerVPSell5,039$61.66$310,704.74View SEC Filing  
2/9/2015Jorge A ValdesInsiderSell8,244$61.67$508,407.48View SEC Filing  
2/2/2015Jeffrey MoySVPSell5,000$60.69$303,450.00View SEC Filing  
1/26/2015Steven Robert PacelliEVPSell24,532$59.67$1,463,824.44View SEC Filing  
1/23/2015Richard DoubledayEVPSell4,000$58.22$232,880.00View SEC Filing  
1/20/2015Jeffrey MoySVPSell5,000$57.58$287,900.00View SEC Filing  
1/20/2015Jess RoperCFOSell7,000$57.34$401,380.00View SEC Filing  
1/15/2015Terrance H GreggChairmanSell15,000$57.84$867,600.00View SEC Filing  
1/13/2015Steven Robert PacelliEVPSell9,468$62.22$589,098.96View SEC Filing  
1/12/2015Steven Robert PacelliEVPSell20,000$59.18$1,183,600.00View SEC Filing  
1/9/2015Jorge A ValdesInsiderSell9,170$57.55$527,733.50View SEC Filing  
1/8/2015John ListerVPSell5,039$57.42$289,339.38View SEC Filing  
1/5/2015Jeffrey MoySVPSell5,000$55.27$276,350.00View SEC Filing  
12/26/2014Andrew K BaloSVPSell10,000$55.27$552,700.00View SEC Filing  
12/23/2014Richard DoubledayVPSell4,000$54.69$218,760.00View SEC Filing  
12/23/2014Steven Robert PacelliEVPSell14,000$54.62$764,680.00View SEC Filing  
12/18/2014Jess RoperCFOSell12,000$56.43$677,160.00View SEC Filing  
12/15/2014Terrance H GreggCEOSell35,000$53.23$1,863,050.00View SEC Filing  
12/8/2014Jorge A ValdesInsiderSell16,000$56.03$896,480.00View SEC Filing  
12/3/2014Eric TopolDirectorSell20,000$55.00$1,100,000.00View SEC Filing  
11/28/2014Terrance H GreggCEOSell59,990$51.51$3,090,084.90View SEC Filing  
11/25/2014Andrew K BaloSVPSell10,000$51.11$511,100.00View SEC Filing  
11/25/2014Terrance H GreggCEOSell55,010$51.04$2,807,710.40View SEC Filing  
11/24/2014Richard DoubledayVPSell4,000$50.36$201,440.00View SEC Filing  
11/24/2014Terrance H GreggCEOSell35,000$51.06$1,787,100.00View SEC Filing  
11/21/2014Terrance H GreggCEOSell10,000$50.50$505,000.00View SEC Filing  
11/19/2014Terrance H GreggCEOSell10,000$51.00$510,000.00View SEC Filing  
11/17/2014Terrance H GreggCEOSell45,000$52.52$2,363,400.00View SEC Filing  
11/12/2014Terrance H GreggCEOSell80,000$53.36$4,268,800.00View SEC Filing  
11/10/2014Jorge A ValdesInsiderSell16,000$51.23$819,680.00View SEC Filing  
10/27/2014Andrew K BaloSVPSell10,000$42.98$429,800.00View SEC Filing  
10/23/2014Richard DoubledayVPSell4,000$43.58$174,320.00View SEC Filing  
10/23/2014Steven Robert PacelliEVPSell14,000$43.60$610,400.00View SEC Filing  
10/13/2014Andrew K BaloSVPSell10,000$40.42$404,200.00View SEC Filing  
10/13/2014John ListerVPSell3,400$40.41$137,394.00View SEC Filing  
10/8/2014Jorge A ValdesInsiderSell16,000$40.29$644,640.00View SEC Filing  
9/25/2014Andrew K BaloSVPSell10,000$40.71$407,100.00View SEC Filing  
9/23/2014Richard DoubledayVPSell4,000$40.32$161,280.00View SEC Filing  
9/23/2014Steven Robert PacelliEVPSell14,000$40.32$564,480.00View SEC Filing  
9/18/2014Jess RoperCFOSell8,000$41.91$335,280.00View SEC Filing  
9/15/2014Terrance H GreggCEOSell35,000$41.14$1,439,900.00View SEC Filing  
9/12/2014John ListerVPSell3,518$43.70$153,736.60View SEC Filing  
9/11/2014Andrew K BaloSVPSell10,000$42.97$429,700.00View SEC Filing  
9/8/2014Jorge A ValdesInsiderSell16,000$42.98$687,680.00View SEC Filing  
8/28/2014Barbara KahnDirectorSell4,000$44.52$178,080.00View SEC Filing  
8/26/2014Jeffrey MoySVPSell16,663$45.30$754,833.90View SEC Filing  
8/26/2014Jonathan T Md LordDirectorSell20,000$45.56$911,200.00View SEC Filing  
8/26/2014Steven Robert PacelliEVPSell30,000$44.56$1,336,800.00View SEC Filing  
8/26/2014Terrance H GreggCEOSell5,000$46.05$230,250.00View SEC Filing  
8/25/2014Andrew K BaloSVPSell10,000$44.12$441,200.00View SEC Filing  
8/25/2014Richard DoubledayVPSell4,000$44.35$177,400.00View SEC Filing  
8/25/2014Steven Robert PacelliEVPSell14,000$44.24$619,360.00View SEC Filing  
8/22/2014Andrew K BaloSVPSell20,000$44.24$884,800.00View SEC Filing  
8/22/2014Terrance H GreggCEOSell13,607$44.46$604,967.22View SEC Filing  
8/21/2014Barbara KahnDirectorSell2,200$43.42$95,524.00View SEC Filing  
8/21/2014Jorge A ValdesInsiderSell10,671$43.58$465,042.18View SEC Filing  
8/21/2014Terrance H GreggCEOSell23,893$44.36$1,059,893.48View SEC Filing  
8/19/2014Richard DoubledayVPSell20,000$45.01$900,200.00View SEC Filing  
8/19/2014Terrance H GreggCEOSell75,000$45.08$3,381,000.00View SEC Filing  
8/18/2014Terrance H GreggCEOSell65,000$44.16$2,870,400.00View SEC Filing  
8/14/2014Terrance H GreggCEOSell25,000$44.24$1,106,000.00View SEC Filing  
8/13/2014Terrance H GreggCEOSell56,107$43.57$2,444,581.99View SEC Filing  
8/11/2014Andrew K BaloSVPSell10,000$44.24$442,400.00View SEC Filing  
8/11/2014Kevin R SayerCOOSell20,000$43.82$876,400.00View SEC Filing  
8/8/2014Jorge A ValdesInsiderSell16,000$43.56$696,960.00View SEC Filing  
7/25/2014Andrew K BaloSVPSell10,000$38.19$381,900.00View SEC Filing  
7/23/2014Richard DoubledayVPSell4,000$38.16$152,640.00View SEC Filing  
7/23/2014Steven Robert PacelliEVPSell14,000$38.28$535,920.00View SEC Filing  
7/18/2014Jess RoperCFOSell8,000$36.01$288,080.00View SEC Filing  
7/15/2014Terrance H GreggCEOSell35,000$36.66$1,283,100.00View SEC Filing  
7/14/2014John ListerVPSell3,500$36.59$128,065.00View SEC Filing  
7/11/2014Andrew K BaloSVPSell10,000$35.93$359,300.00View SEC Filing  
7/8/2014Jorge A ValdesInsiderSell16,000$36.66$586,560.00View SEC Filing  
7/2/2014Jay S SkylerDirectorSell30,000$40.05$1,201,500.00View SEC Filing  
6/25/2014Andrew K BaloSVPSell10,000$40.60$406,000.00View SEC Filing  
6/23/2014Richard DoubledayVPSell4,000$40.98$163,920.00View SEC Filing  
6/23/2014Steven Robert PacelliEVPSell14,000$41.02$574,280.00View SEC Filing  
6/20/2014Jay S SkylerDirectorSell60,000$40.00$2,400,000.00View SEC Filing  
6/18/2014Jess RoperCFOSell8,000$39.17$313,360.00View SEC Filing  
6/16/2014Terrance H GreggCEOSell35,000$37.23$1,303,050.00View SEC Filing  
6/12/2014John ListerVPSell3,500$36.13$126,455.00View SEC Filing  
6/11/2014Andrew K BaloSVPSell10,000$36.63$366,300.00View SEC Filing  
6/9/2014Jorge A ValdesInsiderSell16,000$36.68$586,880.00View SEC Filing  
6/5/2014Richard DoubledayVPSell4,000$35.59$142,360.00View SEC Filing  
5/27/2014Andrew K BaloSVPSell10,000$33.86$338,600.00View SEC Filing  
5/19/2014Jess RoperCFOSell8,000$32.20$257,600.0087,786View SEC Filing  
5/8/2014Jorge ValdesInsiderSell16,000$29.83$477,280.00217,487View SEC Filing  
4/25/2014Andrew BaloSVPSell10,000$34.35$343,500.00159,099View SEC Filing  
4/23/2014Richard DoubledayVPSell4,000$35.92$143,680.00147,523View SEC Filing  
4/23/2014Steven Robert PacelliEVPSell14,000$35.90$502,600.00241,399View SEC Filing  
4/21/2014Jess RoperCFOSell8,000$36.18$289,440.0087,786View SEC Filing  
4/15/2014Terrance GreggCEOSell35,000$34.09$1,193,150.00395,626View SEC Filing  
4/14/2014John ListerVPSell2,884$35.86$103,420.24119,408View SEC Filing  
4/11/2014Andrew BaloSVPSell10,000$35.36$353,600.00159,099View SEC Filing  
4/8/2014Jorge ValdesInsiderSell16,000$35.99$575,840.00217,487View SEC Filing  
3/26/2014Jay SkylerDirectorSell30,000$43.05$1,291,500.00View SEC Filing  
3/25/2014Andrew BaloSVPSell10,000$43.00$430,000.00159,099View SEC Filing  
3/24/2014Steven Robert PacelliEVPSell14,000$42.92$600,880.00241,399View SEC Filing  
3/18/2014Jess RoperCFOSell8,000$46.00$368,000.0087,786View SEC Filing  
3/17/2014Terrance GreggCEOSell45,000$45.25$2,036,250.00395,626View SEC Filing  
3/12/2014Terrance GreggCEOSell30,000$45.50$1,365,000.00395,626View SEC Filing  
3/10/2014Jorge ValdesInsiderSell16,000$46.57$745,120.00203,003View SEC Filing  
3/5/2014Jeffrey MoySVPSell10,000$47.30$473,000.00187,485View SEC Filing  
3/5/2014Terrance GreggCEOSell111,890$47.46$5,310,299.40212,813View SEC Filing  
3/3/2014Terrance GreggCEOSell40,000$44.87$1,794,800.00212,813View SEC Filing  
2/26/2014Jess RoperCFOSell25,000$45.20$1,130,000.0066,508View SEC Filing  
2/25/2014Steven Robert PacelliEVPSell33,368$44.93$1,499,224.24195,865View SEC Filing  
1/23/2014Steven Robert PacelliEVPSell14,000$36.49$510,860.00195,865View SEC Filing  
1/21/2014Jess RoperCFOSell8,000$37.38$299,040.0065,808View SEC Filing  
12/18/2013Jess RoperCFOSell8,000$34.48$275,840.0065,808View SEC Filing  
12/13/2013Terrance GreggCEOSell50,000$34.41$1,720,500.00212,813View SEC Filing  
12/12/2013Nicholas AugustinosDirectorSell11,321$34.40$389,442.4011,130View SEC Filing  
12/10/2013Nicholas AugustinosDirectorSell97,541$33.64$3,281,279.2422,451View SEC Filing  
12/5/2013Terrance GreggCEOSell20,000$34.77$695,400.00212,813View SEC Filing  
12/3/2013Andrew BaloSVPSell14,268$34.21$488,108.28124,297View SEC Filing  
11/15/2013Terrance GreggCEOSell35,000$32.74$1,145,900.00212,813View SEC Filing  
9/3/2013Terrance GreggCEOSell9,000$27.00$243,000.00212,813View SEC Filing  
8/1/2013Terrance H GreggCEOSell9,000$22.15$199,350.00View SEC Filing  
7/1/2013Terrance H GreggCEOSell9,000$22.87$205,830.00View SEC Filing  
6/13/2013Andrew K BaloSVPSell10,000$21.90$219,000.00View SEC Filing  
6/11/2013Jess RoperCFOSell10,361$22.33$231,361.13View SEC Filing  
6/11/2013John ListerVPSell2,000$22.43$44,860.00View SEC Filing  
6/11/2013Steven Robert PacelliEVPSell5,000$22.31$111,550.00View SEC Filing  
6/4/2013Terrance H GreggCEOSell19,000$21.32$405,080.00View SEC Filing  
5/15/2013Jeffrey MoySVPSell5,000$19.97$99,850.00View SEC Filing  
5/13/2013Andrew K BaloSVPSell45,000$19.40$873,000.00View SEC Filing  
5/9/2013Richard DoubledaySVPSell1,272$19.56$24,880.32View SEC Filing  
3/13/2013Andrew K BaloSVPSell15,416$16.53$254,826.48View SEC Filing  
3/11/2013Jay S SkylerDirectorBuy70,000$15.50$1,085,000.00View SEC Filing  
3/11/2013John ListerVPSell4,500$15.75$70,875.00View SEC Filing  
3/11/2013Richard DoubledaySVPSell5,100$15.63$79,713.00View SEC Filing  
2/1/2013Terrance H GreggCEOSell9,000$15.08$135,720.00View SEC Filing  
12/3/2012Terrance H GreggCEOSell5,000$13.24$66,200.00View SEC Filing  
9/4/2012Terrance H GreggCEOSell15,000$13.46$201,900.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Dexcom (NASDAQ DXCM) News Headlines

Source:
DateHeadline
Dexcom (DXCM) Receives Average Recommendation of "Buy" from BrokeragesDexcom (DXCM) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - April 25 at 5:38 AM
New Review of Selecting the Appropriate Continuous Glucose Monitoring System – a Practical Approach ...New Review of Selecting the Appropriate Continuous Glucose Monitoring System – a Practical Approach ...
www.prnewswire.com - April 24 at 9:14 AM
Dexcom (DXCM) Set to Announce Earnings on MondayDexcom (DXCM) Set to Announce Earnings on Monday
www.americanbankingnews.com - April 23 at 7:32 AM
Form 4 DEXCOM INC For: Apr 16 Filed by: GREGG TERRANCE HForm 4 DEXCOM INC For: Apr 16 Filed by: GREGG TERRANCE H
www.streetinsider.com - April 19 at 9:14 AM
Head to Head Contrast: Dexcom (DXCM) & Baxter International (BAX)Head to Head Contrast: Dexcom (DXCM) & Baxter International (BAX)
www.americanbankingnews.com - April 19 at 8:42 AM
Insider Selling: Dexcom (DXCM) Insider Sells 10,000 Shares of StockInsider Selling: Dexcom (DXCM) Insider Sells 10,000 Shares of Stock
www.americanbankingnews.com - April 18 at 10:10 PM
Dexcom (DXCM) Raised to Hold at Zacks Investment ResearchDexcom (DXCM) Raised to Hold at Zacks Investment Research
www.americanbankingnews.com - April 17 at 5:27 PM
Dexcom (DXCM) Downgraded by BidaskClubDexcom (DXCM) Downgraded by BidaskClub
www.americanbankingnews.com - April 16 at 6:31 PM
BidaskClub Downgrades Dexcom (DXCM) to Strong SellBidaskClub Downgrades Dexcom (DXCM) to Strong Sell
www.americanbankingnews.com - April 14 at 5:51 PM
Dexcom (DXCM) Given a $92.00 Price Target at OppenheimerDexcom (DXCM) Given a $92.00 Price Target at Oppenheimer
www.americanbankingnews.com - April 14 at 11:49 AM
Dexcoms (DXCM) Outperform Rating Reiterated at BMO Capital MarketsDexcom's (DXCM) Outperform Rating Reiterated at BMO Capital Markets
www.americanbankingnews.com - April 14 at 9:59 AM
TheStreet Upgrades Dexcom (DXCM) to C-TheStreet Upgrades Dexcom (DXCM) to C-
www.americanbankingnews.com - April 13 at 10:53 AM
This Mornings Technical Outlook on Medical Research Stocks -- Bruker, Charles River Labs, DexCom, and Exact ...This Morning's Technical Outlook on Medical Research Stocks -- Bruker, Charles River Labs, DexCom, and Exact ...
www.prnewswire.com - April 12 at 10:07 AM
Edited Transcript of DXCM presentation 6-Mar-17 9:00pm GMTEdited Transcript of DXCM presentation 6-Mar-17 9:00pm GMT
finance.yahoo.com - April 12 at 10:07 AM
Dexcom (DXCM) Sees Significant Growth in Short InterestDexcom (DXCM) Sees Significant Growth in Short Interest
www.americanbankingnews.com - April 12 at 2:18 AM
BidaskClub Upgrades Dexcom (DXCM) to SellBidaskClub Upgrades Dexcom (DXCM) to Sell
www.americanbankingnews.com - April 11 at 10:10 PM
 Analysts Anticipate Dexcom (DXCM) Will Post Quarterly Sales of $172.68 Million Analysts Anticipate Dexcom (DXCM) Will Post Quarterly Sales of $172.68 Million
www.americanbankingnews.com - April 11 at 6:05 AM
Dexcoms (DXCM) Buy Rating Reaffirmed at StephensDexcom's (DXCM) Buy Rating Reaffirmed at Stephens
www.americanbankingnews.com - April 9 at 1:19 PM
DexCom (DXCM): Notes From Mass General Expert Call - Piper JaffrayDexCom (DXCM): Notes From Mass General Expert Call - Piper Jaffray
www.streetinsider.com - April 9 at 9:30 AM
UPDATE: DexCom (DXCM) PT Raised to $78 at Stephens; Reiterates OverweightUPDATE: DexCom (DXCM) PT Raised to $78 at Stephens; Reiterates Overweight
www.streetinsider.com - April 9 at 9:30 AM
-$0.32 Earnings Per Share Expected for Dexcom (DXCM) This Quarter-$0.32 Earnings Per Share Expected for Dexcom (DXCM) This Quarter
www.americanbankingnews.com - April 9 at 1:22 AM
DexCom Schedules First Quarter 2018 Earnings Release and Conference Call for May 2, 2018 at 4:30 pm Eastern Time.DexCom Schedules First Quarter 2018 Earnings Release and Conference Call for May 2, 2018 at 4:30 pm Eastern Time.
www.businesswire.com - April 4 at 4:53 PM
DexCom Schedules First Quarter 2018 Earnings Release and Conference Call for May 2, 2018 at 4:30 p.m. Eastern Time.DexCom Schedules First Quarter 2018 Earnings Release and Conference Call for May 2, 2018 at 4:30 p.m. Eastern Time.
finance.yahoo.com - April 4 at 4:53 PM
Here's Why Senseonics Holdings Inc. Is Rising TodayHere's Why Senseonics Holdings Inc. Is Rising Today
finance.yahoo.com - April 4 at 4:53 PM
Dexcom (DXCM) Now Covered by Analysts at Goldman SachsDexcom (DXCM) Now Covered by Analysts at Goldman Sachs
www.americanbankingnews.com - April 4 at 8:04 AM
Dexcom (DXCM) Receives New Coverage from Analysts at GuggenheimDexcom (DXCM) Receives New Coverage from Analysts at Guggenheim
www.americanbankingnews.com - April 3 at 9:18 PM
Jefferies Has 4 Health Care and Technology Stock Buys to Start Q2Jefferies Has 4 Health Care and Technology Stock Buys to Start Q2
247wallst.com - April 3 at 9:34 AM
DexCom Is A Takeover Candidate - Cramers Lightning Round (3/29/18)DexCom Is A Takeover Candidate - Cramer's Lightning Round (3/29/18)
seekingalpha.com - April 2 at 9:45 AM
Dexcom (DXCM) Given New $57.00 Price Target at BarclaysDexcom (DXCM) Given New $57.00 Price Target at Barclays
www.americanbankingnews.com - April 1 at 10:20 PM
Dexcom (DXCM) Raised to Hold at ValuEngineDexcom (DXCM) Raised to Hold at ValuEngine
www.americanbankingnews.com - April 1 at 7:35 PM
DexCom, Inc. (DXCM) Given Average Recommendation of "Buy" by BrokeragesDexCom, Inc. (DXCM) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - March 31 at 5:42 AM
DexCom (DXCM) Lifted to Strong-Buy at BidaskClubDexCom (DXCM) Lifted to Strong-Buy at BidaskClub
www.americanbankingnews.com - March 30 at 6:14 PM
DexCom (DXCM) Given a $80.00 Price Target by Piper Jaffray AnalystsDexCom (DXCM) Given a $80.00 Price Target by Piper Jaffray Analysts
www.americanbankingnews.com - March 29 at 11:25 AM
DexCom (DXCM) PT Set at $80.00 by OppenheimerDexCom (DXCM) PT Set at $80.00 by Oppenheimer
www.americanbankingnews.com - March 29 at 11:11 AM
DexCom (DXCM) Upgraded to "Outperform" by BMO Capital MarketsDexCom (DXCM) Upgraded to "Outperform" by BMO Capital Markets
www.americanbankingnews.com - March 29 at 8:36 AM
DexCom (DXCM) Given "Positive" Rating at Canaccord GenuityDexCom (DXCM) Given "Positive" Rating at Canaccord Genuity
www.americanbankingnews.com - March 29 at 8:36 AM
DexCom (DXCM) PT Raised to $80 at Piper Jaffray, Recommends Buying SharesDexCom (DXCM) PT Raised to $80 at Piper Jaffray, Recommends Buying Shares
www.streetinsider.com - March 28 at 4:34 PM
DexCom (DXCM) PT Raised to $85 at Cowen on FDA Approval of G6 CGM System; Upside to 2018/2019 Revenue ...DexCom (DXCM) PT Raised to $85 at Cowen on FDA Approval of G6 CGM System; 'Upside to 2018/2019 Revenue ...
www.streetinsider.com - March 28 at 4:34 PM
DexComs (DXCM) Sell Rating Reaffirmed at Northland SecuritiesDexCom's (DXCM) Sell Rating Reaffirmed at Northland Securities
www.americanbankingnews.com - March 28 at 12:58 PM
FDA Authorizes Marketing of the New Dexcom G6® CGM Eliminating Need for Fingerstick Blood Testing for People with DiabetesFDA Authorizes Marketing of the New Dexcom G6® CGM Eliminating Need for Fingerstick Blood Testing for People with Diabetes
finance.yahoo.com - March 28 at 9:31 AM
Richard Doubleday Sells 2,581 Shares of DexCom, Inc. (DXCM) StockRichard Doubleday Sells 2,581 Shares of DexCom, Inc. (DXCM) Stock
www.americanbankingnews.com - March 27 at 10:33 PM
FDA approves DexComs glucose monitoring systemFDA approves DexCom's glucose monitoring system
finance.yahoo.com - March 27 at 4:30 PM
FDA OKs DexCom G6 integrated CGM systemFDA OKs DexCom G6 integrated CGM system
seekingalpha.com - March 27 at 4:26 PM
DexCom (DXCM) Stock Rating Lowered by BidaskClubDexCom (DXCM) Stock Rating Lowered by BidaskClub
www.americanbankingnews.com - March 27 at 3:30 PM
Today’s Research Reports on Trending Tickers: DexCom and Solid BiosciencesToday’s Research Reports on Trending Tickers: DexCom and Solid Biosciences
finance.yahoo.com - March 26 at 9:41 AM
 Analysts Anticipate DexCom, Inc. (DXCM) Will Post Quarterly Sales of $172.80 Million Analysts Anticipate DexCom, Inc. (DXCM) Will Post Quarterly Sales of $172.80 Million
www.americanbankingnews.com - March 25 at 9:58 AM
DexCom (DXCM) Downgraded to Hold at BidaskClubDexCom (DXCM) Downgraded to Hold at BidaskClub
www.americanbankingnews.com - March 25 at 12:16 AM
Baird Upgrades DexCom (DXCM) to OutperformBaird Upgrades DexCom (DXCM) to Outperform
www.streetinsider.com - March 24 at 4:33 PM
DexCom (DXCM) Given Buy Rating at Northcoast ResearchDexCom (DXCM) Given Buy Rating at Northcoast Research
www.americanbankingnews.com - March 24 at 12:06 PM
Piper Jaffray Companies Analysts Give DexCom (DXCM) a $78.00 Price TargetPiper Jaffray Companies Analysts Give DexCom (DXCM) a $78.00 Price Target
www.americanbankingnews.com - March 23 at 6:50 PM

SEC Filings

Dexcom (NASDAQ:DXCM) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Dexcom (NASDAQ:DXCM) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Dexcom (NASDAQ DXCM) Stock Chart for Wednesday, April, 25, 2018

Loading chart…

This page was last updated on 4/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.